| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33dcf7bd24a87a1ffbe191740e267ff4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_132f6c992fbb0701f20cf916a51b03e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f63ac08b0bb3b28dbcbd769a73e1ed1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c73f2b20726aca749581f5859a7005b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ff7b9ba176c6679113b913dbc5cee04 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N33-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
| filingDate |
2019-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a3a44e0576e86340529796adde8bf63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbe2d66a241dc19d201bef0c6292723d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86f2cd2106592f6102d326db196e2f41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac38ac5383a0e83613bf380f26c1fc4f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_406a33a319cbcf3ab2b5dd0dd473310a |
| publicationDate |
2020-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020139999-A1 |
| titleOfInvention |
Pancreatic cancer treatment |
| abstract |
Methods and composition of treatment of pancreatic cancer are disclosed. Certain embodiments are directed to methods for treating pancreatic cancer comprising administering an effective amount of a composition comprising palmatine or palmatine derivatives to a patient that has cancer. In certain embodiments a chemotherapy agents is administered in combination with palmatine. Certain embodiments are directed to an anti-pancreatic cancer composition comprising palmatine and a chemotherapy agent. |
| priorityDate |
2018-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |